Q2 2024 Holdings
Filed 2024-08-14 | 75 holdings | $3.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Guardant Health Inc | NOTE11/1 | 40131MAB5 | $208.1M | $268,252,000 | 6.5% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $143.0M | $140,838,000 | 4.5% |
| Novocure LTD | NOTE11/0 | 67011XAB9 | $129.8M | $140,834,000 | 4.1% |
| Nuvasive Inc | NOTE 0.375% 3/1 | 670704AJ4 | $110.1M | $114,206,000 | 3.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $104.5M | 759,009 | 3.3% |
| CG Oncology Inc(CGON) | COM | 156944100 | $104.5M | 3,309,507 | 3.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $99.8M | 2,560,573 | 3.1% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $94.1M | 2,392,042 | 3.0% |
| Neogenomics Inc | NOTE 0.250% 1/1 | 64049MAB6 | $90.8M | $116,381,000 | 2.9% |
| Ironwood Pharmaceuticals Inc | NOTE 1.500% 6/1 | 46333XAH1 | $84.6M | $89,740,000 | 2.7% |
| Dexcom Inc | NOTE 0.375% 5/1 | 252131AM9 | $81.2M | $82,700,000 | 2.5% |
| Guardant Health Inc(GH) | COM | 40131M109 | $81.1M | 2,807,968 | 2.5% |
| Insulet Corp | NOTE 0.375% 9/0 | 45784PAK7 | $74.4M | $68,000,000 | 2.3% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $74.0M | 1,669,720 | 2.3% |
| Dexcom Inc | NOTE 0.250%11/1 | 252131AK3 | $73.8M | $73,500,000 | 2.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $71.8M | 166,924 | 2.3% |
| Align Technology Inc(ALGN) | COM | 016255101 | $66.4M | 275,207 | 2.1% |
| Maravai Lifesciences Hldgs I(MRVI) | COM CL A | 56600D107 | $64.6M | 9,024,037 | 2.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $61.0M | 808,303 | 1.9% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $59.1M | 2,514,538 | 1.9% |
| Glaukos Corp(GKOS) | COM | 377322102 | $58.8M | 496,576 | 1.8% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $58.7M | 1,106,905 | 1.8% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $56.7M | 526,357 | 1.8% |
| Alphatec Hldgs Inc | NOTE 0.750% 8/0 | 02081GAB8 | $56.6M | $58,217,000 | 1.8% |
| Sarepta Therapeutics Inc | NOTE 1.250% 9/1 | 803607AD2 | $55.5M | $43,066,000 | 1.7% |
| Bridgebio Pharma Inc | NOTE 2.250% 2/0 | 10806XAD4 | $52.3M | $65,594,000 | 1.6% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $50.8M | 379,443 | 1.6% |
| Travere Therapeutics Inc | NOTE 2.500% 9/1 | 761299AB2 | $48.8M | $56,031,000 | 1.5% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $48.2M | 1,141,678 | 1.5% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $44.9M | 982,209 | 1.4% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $44.7M | 100,500 | 1.4% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $41.8M | 3,035,904 | 1.3% |
| Repligen Corp(RGEN) | COM | 759916109 | $40.8M | 323,509 | 1.3% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $40.8M | 2,898,639 | 1.3% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $39.0M | 70,449 | 1.2% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $38.4M | 2,058,303 | 1.2% |
| Penumbra Inc(PEN) | COM | 70975L107 | $38.3M | 212,594 | 1.2% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $31.9M | 1,107,770 | 1.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $28.9M | 4,438,232 | 0.9% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $28.6M | 189,960 | 0.9% |
| Paragon 28 Inc(FNAUSD) | COM | 69913P105 | $28.4M | 4,150,109 | 0.9% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $27.0M | 797,268 | 0.8% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $25.4M | 1,084,400 | 0.8% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $23.5M | 611,800 | 0.7% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $22.9M | 2,194,900 | 0.7% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $22.2M | 1,382,481 | 0.7% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $19.7M | 107,179 | 0.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $19.6M | 3,006,799 | 0.6% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $14.3M | 1,698,768 | 0.4% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $13.9M | 8,294,950 | 0.4% |